Incyte Corp’s recently made public that its EVP & Chief Medical Officer Stein Steven H unloaded Company’s shares for reported $2.06 million on Dec 02 ’25. In the deal valued at $102.51 per share,20,105 shares were sold. As a result of this transaction, Stein Steven H now holds 63,129 shares worth roughly $6.1 million.
Then, Stein Steven H sold 2,559 shares, generating $263,475 in total proceeds. Upon selling the shares at $102.96, the EVP & Chief Medical Officer now owns 100,327 shares.
Before that, STEVEN STEIN bought 20,105 shares. Incyte Corp shares valued at $2,060,978 were divested by the Officer at a price of $102.51 per share.
Mizuho upgraded its Incyte Corp [INCY] rating to an Outperform from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who increased its forecast for the stock in early November from “a Neutral” to “a Buy”. Oppenheimer also remained covering INCY and has decreased its forecast on October 08, 2025 with a “Perform” recommendation from previously “an Outperform” rating. Wells Fargo revised its rating on August 06, 2025. It rated INCY as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of INCY
On Monday, Incyte Corp [NASDAQ:INCY] saw its stock fall -5.68% to $96.7. Over the last five days, the stock has lost -5.23%. Incyte Corp shares have risen nearly 29.59% since the year began. Nevertheless, the stocks have risen 40.00% over the past one year. While a 52-week high of $109.28 was reached on 11/12/25, a 52-week low of $53.56 was recorded on 04/09/25.
Levels Of Support And Resistance For INCY Stock
The 24-hour chart illustrates a support level at 93.88, which if violated will result in even more drops to 91.07. On the upside, there is a resistance level at 99.97. A further resistance level may holdings at 103.25.
How much short interest is there in Incyte Corp?
A steep rise in short interest was recorded in Incyte Corp stocks on 2025-11-14, growing by 0.13 million shares to a total of 9.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 9.36 million shares. There was a rise of 1.38%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 01, 2025 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $90 price target.
